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Abstract
Comorbid diseases co-occur and progress via
complex temporal patterns that vary among
individuals. In electronic health records
we can observe the different diseases a pa-
tient has, but can only infer the tempo-
ral relationship between each co-morbid con-
dition. Learning such temporal patterns
from event data is crucial for understanding
disease pathology and predicting prognoses.
To this end, we develop deep diffusion pro-
cesses (DDP) to model “dynamic comorbid-
ity networks”, i.e., the temporal relationships
between comorbid disease onsets expressed
through a dynamic graph. A DDP comprises
events modelled as a multi-dimensional point
process, with an intensity function parame-
terized by the edges of a dynamic weighted
graph. The graph structure is modulated by
a neural network that maps patient history to
edge weights, enabling rich temporal repre-
sentations for disease trajectories. The DDP
parameters decouple into clinically meaning-
ful components, which enables serving the
dual purpose of accurate risk prediction and
intelligible representation of disease pathol-
ogy. We illustrate these features in experi-
ments using cancer registry data.
1 INTRODUCTION
The illnesses arise not just from individual causes for
the specific disease but as a complex interaction be-
tween other diseases the patient already had. Iden-
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tifying and understanding the contribution of comor-
bidities to disease progression and outcomes is funda-
mental to medicine and clinical practice. The causal
structure of relationships between diseases can be rep-
resented by networks that are dynamic in nature. For
instance, long-term diabetes increases the risk of car-
diovascular and renal disease making high blood pres-
sure and its complications - such as heart attacks more
likely. The strength of edges between network nodes
changes over time, depending on the entire patient
history. Beyond disease progression, these dynamics
are also prevalent in economics, finance and sociology
(Ahmed & Xing, 2009; Namaki et al., 2011).
In most of these cases, the underlying network dy-
namics are unknown, and what we observe are se-
quences of events spreading over the network. To infer
the latent network dynamics from observed sequences,
one needs to take into account both when and what
events occured in the past since both carry informa-
tion on the mechanisms involved in disease instanti-
ation and progression. Multi-dimensional point pro-
cesses are natural candidates for this problem; they
explicitly model the time period between events as
random variables, and allow them to modulate the in-
tensity function — a stochastic model for the time of
the next event given previous events. However, tra-
ditional parametric models are not expressive enough
to capture network dynamics, i.e. the networks they
learn are static in nature. On the other hand, existing
neural point process models do not entail well-defined
network structure due to their complex parameteriza-
tion.
In this paper, we develop the deep diffusion process
(DDP), a deep probabilistic model for diffusion over
comorbidity networks based on mutually-interacting
point processes as illustrated in Figure 1. We model
the DDP intensity function as an combination of con-
textualized background risk and networked disease in-
teraction. The disease interaction further consists of
three components: (1) static pairwise interactions, (2)
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Figure 1: An Exemplary Realization of DDP. Each node corresponds to a disease ICD-10 code (D64.9: Anemia, N18.9:
Renal failure, I63.9: Cerebral infarction, E11.9: Diabetes, I70.209: Atherosclerosis, M81.0: Osteoporosis, and I25.10: Heart disease.) Edge
weights are depicted via their thickness. The left panels show the evolution of the disease network, and the righmost
panel shows the intensity functions of three selected nodes. Onset of heart disease (at t1) triggers spikes in the intensity
functions of diabetes and anemia, making them more likely in the future. The onset of diabetes (at t2) elevates the risk of
anemia (i.e., thicker edge), which consequently occurs at t3. Edge weights are modulated by a neural network over time.
time influence, and (3) dynamic influence factors. The
first two components are standard in point process
models whereas the last component makes use of a
deep neural network to (dynamically) update the dis-
ease’s influence on future events. The introduction of
neural networks does not only add to model capac-
ity, but also enables principled predictions based on
clinically interpretable parameters which map the pa-
tient history on to personalized comorbidity networks.
This brings us closer to understanding the underlying
disease mechanisms, which as we hypothesize, leads to
better out-of-sample and out-of-domain performances.
In our experiments, we provide encouraging results in
this direction, with better performance of our model
in medical data from a different domain.
2 RELATED WORK
In this Section, we highlight previous approaches based
on point process formalism, and techniques specifically
used in medicine that are relevant to our problem.
2.1 Point Processes for Event Streams
2.1.1 Parametric Models
Gomez-Rodriguez et al. (2012) introduced one of the
earliest algorithms for discovering latent networks
from sequences of events with a transmission pro-
cess influenced only by the most recent event. The
cHawkes model (Choi et al., 2015) removes the
Markovian assumption by modelling the event stream
as a Hawkes Process where past events temporarily
raise the probability of future events. The resulting
network captures the pairwise interaction between any
two events. However, the influence of the combinations
of previous events and their timing is not accounted
for in the network structure. As a result, the learnt
network is constant for all event streams at all time.
Hence, we refer to it as a static population-level net-
work.
2.1.2 Neural Network Based Models
Several recent publications have been focusing on ex-
panding the flexibility of point process models by using
recurrent neural networks (RNN).
Du et al. (2016) models the inter-arrival time between
consecutive events as a univariate point process and
annotates each event with a marker to indicate the
event type. Importantly, the marker and the arrival
time of the next event are conditionally independent
given the history. The independence assumption im-
poses limitations on the expressiveness of the model
as there is only one underlying intensity function for
all types of events. Neural Hawkes (Mei & Eisner,
2017) models the intensity function directly as a con-
tinuous time LSTM. The resulting model has much
better flexibility and has achieved the state-of-the-art
performance on a variety of prediction tasks. However,
the model does not generate a well-defined network
between events and it lacks interpretability in general
as the hidden state of the RNN do not correspond to
clinically meaningful variables.
More recently, the RPPN model (Xiao et al., 2019) in-
corporates temporal attention mechanism to improve
the interpretability of neural point process. The model
requires a separate attention function for each possi-
ble event type in order to connect the observed past
with the unobserved future. This may not be an is-
sue when all types of events occur relatively often, but
in the medical domain, the majority of diseases have
low prevalence in the population1, which means the
attention functions for these diseases may not be ad-
1For example, heart disease is perceived to be very com-
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equately trained due to scarcity of data. Lamprier
(2019) also considered applying neural networks to
information diffusion modelling, although the model
does not allow the same type of event to occur more
than once. In the medical setting, recurrence of previ-
ous diseases carries important information about the
patient’s health condition. It is also of interest to pre-
dict the future recurrence of existing morbidities.
Table 1: Point Process intensity functions. Subscript v
denotes event type. f is the context vector. γ is the time-
influence kernel. ht is the outputs of RNN units and A·,v
is the output of event v’s attention function. ζ and σ are
softplus and sigmoid functions respectively.
Model Background Temporal Dependence
Poisson Process µv(t) 0
Hawkes Process µv(t)
∑
i:ti<t
αvi,vγvi,v
cHawkes µv(t,f) Same as above
Neural Hawkes 0 ζ(wvht)
RPPN 0 ζ(w
∑
i:ti<t
Avi,vhtiγvi,v)
DDP µv(t,f)
∑
i:ti<t
αvi,vγvi,vσ(wht)
2.2 Medical Disease Networks
Within the medical community, understanding disease
networks and associated comorbidities — i.e. any two
or more diseases that occur in one person at the same
time — is fundamental to the diagnosis and treatment
of patients. Many rule-based scoring models are based
on empirical association of symptoms and clinical out-
comes. For example, the Charlson Comorbidity Index
(Charlson et al., 1987) was proposed as early as 1987
to predict the ten-year mortality for a patient by sum-
ming up the risk indices associated with various co-
morbid conditions. The index remains the preferred
approach in medical community to represent comor-
bidity history (Quan et al., 2011).
Recent works have also investigated the construction of
data-driven dynamic disease networks (Hu et al., 2019;
Lee et al., 2019; Beck et al., 2016; Hidalgo et al., 2009).
However, with no exception, the networks in these
works are constructed in two steps. First, certain pairs
of diseases are linked together based on population
level statistics such as risk ratio or temporal corre-
lation. Next, the disease pairs are pieced together into
longer trajectories or networks. Since all the informa-
tion used in this process is on population level, the
resulting graph is not personalized. Furthermore, con-
structing the network by combining pieces usually im-
plies strong independence assumptions e.g. Markovian
assumption, which rarely holds in disease progression
mon but it actually occurs in only 1.07% of adults accord-
ing to official statistics (NHS, 2019a). Rare diseases often
have prevalence lower than 0.01%.
(a real example is given in the appendix). Therefore,
the dynamic aspect of disease progression is not ade-
quately represented.
The main contribution of this work is to augment the
above approaches by modelling the disease network it-
self as an individualized dyanmic graph. This allows us
to model more complex temporal interactions between
diseases as well as provide personalized predictions.
3 DEEP DIFFUSION PROCESS
3.1 Dynamic Network Representation
Consider a dynamic network Gt = (V,Lt, Et,Wt) con-
sisting of a set of vertices V = {1, ...,K} annotated
with binary labels Lt = {0, 1}K , and a set of directed
edges Et weighed by Wt = R+|E|. The vertices V cor-
respond to the set of all possible event types. At any
time, a vertex v has label lv = 1 if a type v event has
occurred or lv = 0 otherwise. The edge set, formally
defined as E ⊆ {(vi, vj)|vi, vj ∈ V, lvi = 1}, contains
edges that link an observed vertex vi to another vertex
vj if vi modulates vj ’s chance of occurrence. The edge
weights Wt represent the strength of such modulation
effect between events (Refer to Figure 1).
While we do not observe the network directly at each
time, we do have access to individual trajectories
through the network, available as a sequence of events
and corresponding time points,
H = {(t1, v1), ..., (tn, vn)} (1)
where ti ∈ R+ is the time of occurrence and vi ∈ V is
the associated event type. From the event sequence,
one can immediately derive the vertex label Lt for
t ≤ tn. Since the vertex set V is fixed a-priori de-
pending on the problem scope, the remaining unknown
components of the graph are the label Lt for t > tn as
well as the weighted edges Et, Wt for t > 0.
Determining the future vertex label is known as event
prediction, whereas uncovering weighted edges corre-
sponds to network inference. Our goal is to devise a
model that addresses both problems simultaneously.
3.2 Preliminaries on Point Process
Before formally introducing the DDP model, we first
recapitulate several key concepts of point process.
Lying at the core of point processes is the intensity
function λv(t), which is the probability of event v
occurring in time window [t, t + dt) given a history
Ht := {(ti, vi) : ti < t}, i.e.,
λv(t)dt := Pr(event of type v in [t, t+ dt)|Ht) (2)
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As we can see in Table 1, different point process models
have different parameterizations of the intensity func-
tion ranging from the simplest Poisson process to the
complex Neural Hawkes and RPPN. However, once the
intensity function is given, many interesting properties
can be readily derived. For example, the likelihood of
an observed sequence HT is given by
L(θ;HT ) :=
∏
(ti,vi)∈HT
λvi(ti) exp
(
−
∫ ti
ti−1
λ(τ)dτ
)
,
(3)
where λ(t) =
∑
v∈V λv(t) and θ is the collection of all
free parameters in the model. As another example, the
probability of an type v event happening at a specific
time ti+1 > t is given by
P (vi+1 = v |Ht, ti+1) = λv(ti+1)
λ(t)
(4)
and the occurrence time of the next event is given by
P (ti+1 = t |HT ) = λ(t) exp
(
−
∫ t
ti
λ(τ)dτ
)
(5)
The model can be trained in multiple ways. In general,
one can maximize the likelihood function 3 via stochas-
tic gradient descent. If the integral term does not have
a closed form, it can be approximated by Monte Carlo
sampling as done in Mei & Eisner (2017). In addition,
it is also possible to train the model by minimizing the
prediction loss based on (4) and (5) (Du et al., 2016).
3.3 Model Specification
This section presents the Deep Diffusion Process — a
deep probabilistic model for inferring network dynam-
ics while accurately predicting future events.
3.3.1 intensity function
Our objective is to enrich the intensity function in or-
der to capture the time-dependent disease-to-disease
relationships. To this end, we decompose the overall
intensity function into two additive components:
λv(t) = µv(f) +
∑
ti<t
gv(vi, ti,Hti , t). (6)
The first term captures the occurrence of events due
to static exogenous risk factors f . For example, it
can model the increased risk of heart attack among
the obese patients. The second term models the im-
pact from past events. Each historical event adds an
“impulse” gv to the intensity function of event v de-
pending on the event type vi, the timing ti, and, most
importantly, the event history Hti at the time. This
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Figure 2: Schematic of the DDP Architecture.
decomposition allows modeling the impact of exoge-
nous factors and that of past events separately.
Next, we introduce the parametric form to capture the
impact from past events as follows:
gv(vi, ti,Hti , t) = αvi,v · γvi,v(t− ti) · wi(Hti). (7)
The parameter αvi,v captures the instantaneous im-
pact from event vi to v. We use α to denote the ma-
trix that contains all the αvi,v between any two events.
The time influence kernel γvi,v(t− ti) captures the de-
cay or increase of previous events’ influence. It is a
non-negative function defined on R+ and integrates
to one. One common choice is the exponential kernel
γvi,v(t− ti) = βvi,v exp(−βvi,v(t− ti)).
The last component, wi(Hti) ∈ [0, 1], is the (dynamic)
influence factor that depends on the full patient his-
tory. It is learned by an RNN applied to the sequence
of past events. As shown in Figure 2, the event vi is
encoded through an embedding ei ∈ RD, which to-
gether with the time gap ∆ti := ti − ti−1 are fed into
the recurrent layer as follows:
hi = LSTM(ei ∆ti, ht−1), (8)
where hi is the LSTM output. In our implementation,
we used standard LSTM with the time gap as an ad-
ditional input dimension as shown in (8). However,
we note that any continuous-time RNN (e.g., phased
LSTM (Neil et al., 2016)) is applicable. The influence
factor wi is then given by
wi = σ(hi ·W + b), (9)
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where W and b are parameters to be learned, and σ(.)
is the sigmoid function.
For training, we use a loss function comprising the like-
lihood function L(HT ; θ) in (3) and the cross entropy
loss lp(HT ; θ) for event type prediction, i.e.,
θ∗ = argmaxL(HT ; θ)− η · lp(HT ; θ) (10)
where η > 0 is a hyperparameter that trade -off the
two objectives, and is determined from a validation set.
The loss function in (10) encapsulates our dual objec-
tive of a faithful representation for the observed event
sequence and the ability to predict the next event.
3.4 Dynamic Network Inference
The parameter α, the time influence kernel γ and the
influence factors wi jointly define the network struc-
ture at time t. α is the baseline matrix that encodes
static pairwise relationships. The larger the value of
αuv, the more influence event u will have on event v on
average. The time influence kernel further modulates
the link strength based on the time gap between the
occurrence of events.
The influence factor wi modulates α and enables the
network structure to adapt to the observed event se-
quence. Based on the full history of past events, the
influence factor may strengthen or diminish the im-
pact of one particular event and thus modifies all its
outgoing links. Therefore, at time t, the directed edge
v → u will have weight
Wv→u(t) =
∑
(ti,vi)∈HT
vi=v
αv,u · γv,u(t− ti) · wi. (11)
It is worth highlighting that the resulting graph is dy-
namic in two aspects. First, the influence factor wi is
updated for each event vi based on the full event his-
tory up to that point. Depending on the combination
and the timing of historical events, the influence factor
for subsequent events will differ, leading to a different
graph structure. Secondly, the time influence kernel γ
modulates the edge weight as time moves on.
It is often desirable for the graph to have a sparse
structure i.e. Wv→u = 0 for many pairs of events v, u.
We can introduce a L1 regularization term for αmatrix
to encourage sparsity as proposed in Choi et al. (2015).
Lastly, we note that sometimes it is required to con-
struct a population-level static graph instead of a dy-
namic graph to capture the high-level event interac-
tion. Static edge weights can be found by averaging
out the dynamic components in equation 11 as follows
Wv→u = αv,uE[wi], (12)
where the expectation represents the average influence
factor of event v.
4 EXPERIMENTS
In this Section, we utilize data from a large-scale can-
cer registry to evaluate DDP2. Throughout our experi-
ments, we evaluate DDP with respect to three aspects:
(a) its ability to extract interpretable disease networks
that are sensible in the light of current medical liter-
ature (Section 4.2), (b) its accuracy in predicting dis-
ease pathways (Section 4.3), and (c) its generalizability
to out-of-domain datasets (Section 4.4).
4.1 Data Description
We used national registry data for a cohort of colorec-
tal cancer patients diagnosed between 2011 and 2015.
The data comprises 268,000 observations of 100 com-
mon diagnoses for 54,000 patients. Each patient is
associated with up to 15 comorbidities. The earliest
diagnoses date back to the 1990s, which gives us a
fairly broad timescale to study the progression of col-
orectal cancer. In addition to the primary dataset de-
scribed above, we have also considered data for 25,000
patients with stomach cancer. It is well understood
that patients with stomach cancer are exposed to dif-
ferent risk factors from patients with colorectal cancer
(Miller, 1982; Drasar & Irving, 1973). Therefore, we
use this dataset as an out-of-domain test set to val-
idate transferability and robustness of DDP.
4.2 Colorectal cancer comorbidity networks
Heterogeneity of disease pathways among patients can
be quantified by measuring the distance between their
comorbidity networks. A commonly used metric for
measuring distance between graphs is the Jaccard in-
dex as illustrated in Figure 3 (a) (Real & Vargas,
1996). To handle weighted graphs, we use the weighted
Jaccard index J(X,Y ) =
∑
imin(xi,yi)∑
imax(xi,yi)
where xi and yi
are the edge weights in two graphs X and Y. Within a
population, the average Jaccard distance Javg between
any two individual networks measures the heterogene-
ity of the population, i.e.,
Javg =
∑
n<m 1− J(Gn, Gm)(
N
2
) , (13)
where N denotes the size of population. The larger
the average distance, the more spread out the popula-
tion. Since the disease networks are time-varying, we
compute Javg(t) based on the the networks at time t
to reflect the heterogeneity at that moment.
Patient pathways get more heterogeneous over
time. In Figure 3 (b), we track Javg over time (refer-
enced to the date of initial diagnosis). We can readily
2Implementation details are provided in the appendix
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Figure 3: (a) Illustration of the Jaccard index between two exemplary graphs. (b) heterogeneity of comorbidity networks
increases over time in colorectal cancer pathways. (c) Onset of a comorbidity modulates future pathways.
see that the comorbidity networks learned by DDP
become increasingly heterogeneous as time progresses.
This reflects the fact that as a patient gets older, more
comorbidities will occur and the subsequent disease
pathway will become more complex. The increase in
heterogeneity also highlights the need for modeling co-
morbidities with a personalized method since any one-
size-fits-all approach will under-appreciate the diver-
sity occurring later in the pathway. The ability of
DDP to accurately predict the heterogeneity of col-
orectal cancer pathways is assessed in Section 4.3.
Figure 3 (c) shows how the network dynamically
adapts to “influencers”, diseases which trigger a large
variety of comorbidities and complications. The figure
displays change in Javg before and after a disease on-
set relative to the population average. Positive value
means increase in heterogeneity relative to the pop-
ulation, negative value otherwise, and zero means no
change. Time is normalized so that the disease of inter-
est always occurs at time 0. The red, blue and orange
lines represent chronic obstructive pulmonary disease
(COPD), Type 2 diabetes mellitus and heart failure
respectively. It is well-established in the medical liter-
ature that all three types of diseases have complex het-
erogeneous comorbidity pathway (Fabbri et al., 2008;
Stratton et al., 2000). This is clearly reflected in Fig-
ure 3 (c) where the onset of these diseases triggers an
immediate and persistent increase in the heterogene-
ity of comorbidity networks. On the other hand, the
green line represents varicose veins of lower extremi-
ties, a mild condition that often does not need treat-
ment (NHS, 2019b). It is thus unsurprising to see that
patients with this condition usually have less hetero-
geneous disease networks than the average.
The above analysis shows DDP’s ability to adjust the
subsequent comorbidity pathway based on the occur-
rence of individual diseases. This high resolution view
can help medical researchers better understand the
progression and taxonomy of diseases.
Individual-level comorbidity networks. Figure
4 depicts the evolution of the dynamic comorbidity
network of five common gastrointestinal disorders (for
one patient’s pathway) as inferred by DDP — the
comorbidities included: diverticular diseases (ICD-10
code K57), intestinal disorders (K63), benign neo-
plasm in the colon and rectum (D12), diverticular dis-
eases (K57), and ulcerative colitis (K52). The inten-
sity function corresponding to the patient’s trajectory
is shown in the bottom panel. Each edge’s thickness
in the network corresponds to the likelihood of the dis-
ease designating the receiving node to occur at a given
time step. The individual patient’s dynamic network
is contrasted with a static network (upper right panel)
constructed directly from raw data by counting the co-
occurrences of each pair of comorbidities and weighting
edges accordingly.
As we can see in Figure 4, the DDP comorbidity net-
work is fairly dense at each time step, which suggests
that the diseases are related. In fact, numerous med-
ical publications have examined associations between
these diseases. For example, it has been established
that a lack of dietary fiber intake underlies the onset of
diverticular diseases, intestinal disorders, and tumours
of the colon and rectum (Painter & Burkitt, 1971;
Burkitt et al., 1972). Furthermore, there are strong
epidemiological evidences of associations between tu-
mours of colon and rectum, diverticular diseases, and
ulcerative colitis (Ekbom et al., 1990; Burkitt, 1971).
Figure 4 shows that the dynamics of the inferred in-
dividualized comorbidity network cannot be deduced
from the approach presented in Beck et al. (2016).
That is, at each time step the RNN component of
the DDP adapts the weights on the network edges to
reflect the impact of previous diagnoses on the odds
of future ones. Moreover, the weights of the network
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Figure 4: The dynamic comorbidity network learned by DDP for an individual patient at three time steps, together with
the corresponding intensity function. Nodes for diseases that have not occurred are colored in gray, and disease already
diagnosed are assigned a distinct color. Edge thickness correspond to the disease likelihood at the given time step. In
the upper left panel, we plot the Jaccard distance of the patient’s network with respect to the average population as a
function of time (on a logarithmic scale). The static comorbidity network obtained by counting disease co-occurrences
and using the counts as graph edges is depicted on the right panel.
edges reflect the timing at which future comorbidities
are expected to occur — for instance, D12 occurs only
23 days after diagnosis, which was correctly antici-
pated by the DDP network as it assigned a large weight
to the edge connecting the (pre-existing comorbidity)
K62 and D12 at diagnosis time. On the contrary, K57
occured more than 8 months after diagnosis, which
also was anticipated by DDP model having assigned a
smaller weight to edges flowing into K57 node.
By measuring the average (Jaccard) distance between
the comorbidity network of the patient at hand and
those of the overall patient population (upper left
panel of Figure 4), we can see that the patient’s net-
work diverges from the typical population-level path-
way as time progresses. This emphasizes the impor-
tance of the personalization aspect of the DDP model
in predicting patient prognosis in later stages of the
disease as we will show in the next Section.
4.3 Predicting colorectal cancer pathways
Prediction targets and evaluation metric. Each
individual patient has a unique disease pathway and a
good representation of their health trajectory should
enable differentiating these pathways. We evaluate
how well DDP discerns the future disease pathways
by predicting the next event. Given a disease history
Ht = {(ti, vi) : ti < t}, the models try to predict the
probability of having a disease vi+1 at time ti+1. The
time ti+1 represents the time of the next disease onset
available in the dataset. We chose to predict the in-
cidental risk at a given time due to the nature of our
data. For most chronic diseases including cancer, the
diagnosis may occur much later than the actual onset.
Hence the true disease onset time as well as the time
between disease onsets are never observed. By focus-
ing on predicting the diseases at known diagnosis time,
evaluation becomes more objective and less prone to
unknown variation. We calculate the Area Under ROC
(AUC) score for predicting prevalent comorbidities.
Benchmarks. We compare the performance of DDP
with Neural Hawkes (Mei & Eisner, 2017), cHawkes
(Choi et al., 2015), Charlson Score (Charlson et al.,
1987), and RETAIN (Choi et al., 2016), which is a re-
current neural network with temporal attention mech-
anism akin to RPPN (Xiao et al., 2019). Section 2
contains a detailed review of these models.
Results. The results are shown in Table 2. In five out
of eight cases DDP achieved the best performance. In
the rest three cases, the performance of DDP is compa-
rable to that of Neural Hawkes or RETAIN. However,
in these three cases, DDP does not only offer a com-
petitive predictive accuracy, but infers the comorbid-
ity network as well — comorbidity networks cannot
be straightforwardly inferred from the parameters of
Neural Hawkes and RETAIN. This does not only pro-
vide more elaborate interpretability, but as we show in
Section 4.4, it enables better generalization to out-of-
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Table 2: AUC (± 95% confidence intervals) performance for all baselines. Best performance is highlighted in bold font.
ICD-10 code DDP Neural Hawkes cHawkes Charlson RETAIN
I50 0.74 ± 0.0114 0.72 ± 0.0127 0.69 ± 0.0136 0.68 ± 0.0111 0.73 ± 0.0123
N39 0.64 ± 0.0085 0.62 ± 0.0085 0.59 ± 0.0083 0.58 ± 0.0079 0.65 ± 0.0085
A41 0.72 ± 0.0091 0.72 ± 0.0092 0.71 ± 0.0091 0.60 ± 0.0098 0.70 ± 0.0101
D12 0.69 ± 0.0053 0.67 ± 0.0055 0.66 ± 0.0055 0.59 ± 0.0055 0.66 ± 0.0059
E86 0.72 ± 0.0225 0.72 ± 0.0235 0.69 ± 0.0222 0.52 ± 0.0222 0.58 ± 0.0222
I25 0.79 ± 0.0081 0.77 ± 0.0089 0.77 ± 0.0087 0.63 ± 0.0085 0.77 ± 0.0084
K63 0.68 ± 0.0061 0.64 ± 0.0064 0.64 ± 0.0063 0.60 ± 0.0060 0.65 ± 0.0065
K83 0.69 ± 0.0217 0.68 ± 0.0225 0.66 ± 0.0209 0.63 ± 0.0200 0.62 ± 0.0224
Table 3: Out-of-domain AUC performance for all baselines. Best performance is highlighted in bold font.
ICD-10 code DDP Neural Hawkes cHawkes Charlson RETAIN
I50 0.73 ± 0.0089 0.69 ± 0.0091 0.65 ± 0.0102 0.67 ± 0.0195 0.71 ± 0.0093
N39 0.65 ± 0.0063 0.56 ± 0.0066 0.59 ± 0.0064 0.62 ± 0.0142 0.63 ± 0.0066
A41 0.69 ± 0.0065 0.59 ± 0.0070 0.65 ± 0.0070 0.62 ± 0.0142 0.66 ± 0.0072
D12 0.68 ± 0.0065 0.56 ± 0.0068 0.66 ± 0.0065 0.57 ± 0.0147 0.63 ± 0.0078
E86 0.65 ± 0.0127 0.52 ± 0.0125 0.62 ± 0.0121 0.55 ± 0.0321 0.56 ± 0.0122
I25 0.78 ± 0.0049 0.66 ± 0.0058 0.75 ± 0.0054 0.59 ± 0.0117 0.75 ± 0.0053
K63 0.65 ± 0.0077 0.58 ± 0.0079 0.60 ± 0.0078 0.57 ± 0.0164 0.63 ± 0.0083
K83 0.69 ± 0.0126 0.60 ± 0.0135 0.65 ± 0.0123 0.57 ± 0.0284 0.63 ± 0.0128
domain data as we will. In addition, we can readily see
that DDP always outperforms cHawkes and the Charl-
son Score. This suggests that the history-independent
triggering mechanics of cHawkes and Charlson score
do not adequately capture the disease complexity.
4.4 Transferability to other types of cancer
Finally, we applied all baselines originally trained on
the primary dataset (colorectal cancer) to the out-of-
domain dataset (stomach cancer) without re-training.
All other aspects of the experimental setup remains
the same as the previous Section. The results are il-
lustrated in Table 3. We can clearly see that DDP out-
performs all the benchmarks including Neural Hawkes
by a big margin on the out-of-domain samples.
We performed a post-hoc analysis to better understand
what the DDP model has learned. First, we performed
Chi-squared tests to test whether the prevalence of in-
dividual diseases or the occurrence of disease pairs are
different in the two data sets. In both cases, the test
concluded that the distributions are different.(p-value
< 0.001). This finding suggests that the disease net-
works constructed based on population level statistics
such as those reviewed in Section 2.2 will tend to be
different for the two datasets. Next, we randomly
sampled a subset of patients from each of the two
datasets and calculated Jaccard distance within and
between the datasets. Student’s t-test concluded the
average distance between two groups are smaller than
the distance within the group (p-value < 0.01). This
indicates that the graph heterogeneity across datasets
are smaller than the one within. In other words, the
disease network learned by DDP applies to both sets
of patients and is generalizable across cancer sites.
5 CONCLUSION
In this paper, we developed DDP that utilizes deep
neural networks to enable both accurate prediction of
disease trajectories and interpretable representations
of disease pathways. Combining the findings in Section
4, we can see that DDP can offer more nuanced un-
derstanding of disease progression mechanisms, more
accurate prediction of patient pathways, and better
generalizability across different diseases. By taking
into account the full disease history, the learned DDP
comorbidity networks are well equipped to deal with
individual-level disease trajectories in a data-driven
fashion, improving over existing one-size-fits-all clini-
cal guidelines. The DDP model transferability is a ma-
jor advantage in medical applications where the data
for certain sub-populations are still scarce (e.g. in rare
diseases). Moreover, the comorbidity networks uncov-
ered by DDP may enable researchers to formulate hy-
potheses about the causal relations between diseases.
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